Back to mobile site

Canaccord Genuity Maintains a 'Buy' on Vascular Solutions (VASC); Raising PT After Strong Results

April 25, 2012 9:44 AM EDT
Get Alerts VASC Hot Sheet
Price: $56.00 --0%

Rating Summary:
    0 Buy, 5 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Vascular Solutions (NASDAQ: VASC) price target raised to $15.00.

Analyst, Jason R. Mills, said, "Q1 results were strong, which is encouraging following a couple of lackluster quarters. Sales beat expectations as ASPs in the Hemostat business held in better than expected. The new ClosureFAST reprocessing deal got off to a great start, while Guideliner delivered again – up 45% Y/Y. VASC increased 2012 guidance modestly."

"GuideLiner continues to do well and ClosureFast is a bonus (we would like to see one more solid quarter to know if the momentum is real). The company also is looking to add on complementary revenue through M&A, which is not in guidance or our model."

For an analyst ratings summary and ratings history on Vascular Solutions click here. For more ratings news on Vascular Solutions click here.

Shares of Vascular Solutions closed at $10.55 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change